Urinary Incontinence Therapy Chair Market Global Report 2026

The urinary incontinence therapy chair market size has grown strongly in recent years. It will grow from $0.39 billion in 2025 to $0.43 billion in 2026 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to rising prevalence of urinary incontinence, growing awareness of pelvic floor health, increasing demand for non-surgical treatment options, expanding geriatric population, improving access to rehabilitation services.

The urinary incontinence therapy chair market size is expected to see strong growth in the next few years. It will grow to $0.62 billion in 2030 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to growing demand for outpatient pelvic floor therapies, increasing investments in rehabilitation infrastructure, rising adoption of advanced electromagnetic therapy devices, expanding women's healthcare services, increasing availability of specialized pelvic health clinics. Major trends in the forecast period include increasing adoption of non-invasive pelvic floor rehabilitation therapies, growing preference for electromagnetic pelvic floor strengthening treatments, rising demand for drug-free urinary incontinence management, expanding utilization of pelvic floor therapy chairs in rehabilitation programs, increasing focus on early intervention for pelvic floor disorders.

The increasing prevalence of urinary incontinence is expected to propel the growth of the urinary incontinence therapy chair market going forward. Urinary incontinence refers to the involuntary leakage of urine caused by a loss of bladder control due to weakened pelvic floor muscles, nerve dysfunction, aging, pregnancy, childbirth, prostate conditions, or other underlying medical disorders. The prevalence of urinary incontinence is rising due to aging populations and the growing incidence of obesity, chronic diseases, childbirth-related pelvic floor disorders, and prostate surgeries. Urinary incontinence therapy chairs address the growing prevalence of urinary incontinence by offering non-invasive pelvic floor rehabilitation that strengthens muscles, improves neuromuscular control, and alleviates symptoms without requiring surgery or medication. For instance, in August 2024, the National Center for Biotechnology Information (NCBI), a US-based federal agency, reported that approximately 24% to 45% of women experience urinary incontinence. Among women aged 20 to 39, around 7% to 37% experience some level of urinary incontinence. Among women aged over 60, approximately 9% to 39% experience urinary incontinence daily. Therefore, the increasing prevalence of urinary incontinence is contributing to the growth of the urinary incontinence therapy chair market.

The rising obesity rates are expected to propel the growth of the urinary incontinence therapy chair market going forward. Obesity is a medical condition characterized by excessive accumulation of body fat that can negatively impact overall health. Increasing obesity rates are driven by higher consumption of calorie-dense foods, sedentary lifestyles, and declining levels of physical activity. Urinary incontinence therapy chairs support obesity-related healthcare needs by providing a non-invasive treatment approach that strengthens pelvic floor muscles, enhances bladder control, and reduces urinary leakage associated with increased body weight. For instance, in May 2025, according to Gov.UK, a UK-based government agency, between 2023 and 2024, an estimated 64.5% of adults aged 18 years and above in England were overweight or living with obesity, compared with 64.0% during 2022 to 2023. Therefore, the rising obesity rates are contributing to the growth of the urinary incontinence therapy chair market.

Key companies operating in the urinary incontinence therapy chair market are focusing on expanding non-invasive pelvic floor rehabilitation solutions through advanced electromagnetic stimulation technologies to improve treatment outcomes and enhance patient access. Non-invasive pelvic floor rehabilitation solutions are transforming urinary incontinence treatment by strengthening pelvic floor muscles through advanced electromagnetic stimulation without the need for surgery or medication. For example, in July 2026, Ruby Hall Clinic, an India-based multi-specialty hospital and healthcare provider, launched a dedicated Pelvic Floor Rehabilitation Program featuring the UI Cube, an advanced electromagnetic stimulation chair that delivers automated pelvic floor muscle training through Kegel exercises to treat urinary incontinence, strengthening the adoption of non-invasive urinary incontinence therapy chairs.

Major companies operating in the urinary incontinence therapy chair market report are BTL Industries, Guangzhou Shefmon Beauty Equipment Co. Ltd., Guangzhou Longest Science & Technology Co. Ltd., Beijing ADSS Development Co. Ltd., Shenzhen XFT Medical Ltd., Beijing KES Biology Technology Co. Ltd., Zimmer MedizinSysteme GmbH, Iskra Medical, Guangzhou Konmison Electronic Technology Co. Ltd., Guangzhou Sunwin Technology Co. Ltd., Guangzhou T&B Beauty Equipment Co. Ltd., OFAN Intelligent Technology Co. Ltd.

North America was the dominant region in the urinary incontinence therapy chair market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the urinary incontinence therapy chair market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the urinary incontinence therapy chair market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.